Objective To explore the active ingredients of shengxian and jinshuiliujun decoction with the method of network pharmacology,and to verify the experimental mechanism of its treatment of silicosis.Methods In May 2023,the active ingredients and targets of drugs in shengxian and jinshuiliujun decoction were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)database.The target of silicosis disease was screened by databases such as Genecards,Disease Gene Network(DisGeNET),Comparative Toxicogenomics Database(CTD),etc.The screened drug targets and disease targets were intersected to obtain the target set of shengxian and jinshuiliujun decoction for the treatment of silicosis.Protein-protein interaction(PPI)network analysis was performed on the target set through STRING database,and core target genes were screened.GO enrichment analysis and KEGG pathway analysis of intersection genes were performed based on Metascape database,and molecular docking verification of key components and targets of shengxian and jinshuiliujun decoction was carried out.Twenty-four adult male SD rats with SPF grade were randomly divided into control group,model group and TCM intervention group,with 8 rats in each group.The dust-stained rat model was prepared by non-tracheal exposure of 1 ml silica suspension(50 mg/ml)in one go,and TCM intervention group was given shengxian and jinshuiliujun decoction[6g/(kg·d)]on the second day.The CT of the lungs of each group was observed 28 days after the dust-stained rat model.Paraffin sections of rat lung tissues were prepared and stained with Hematoxylin-Eosin(HE)and Masson.Western blot was used to verify the expression of core target-related proteins in rat lung tissues after the intervention of shengxian and jinshuiliujun decoction for 28 days,and the differences in protein expression between groups were compared by one-way analysis of variance.Results A total of 205 active ingredients and 3345 active compounds were selected from shengxian and jinshuiliujun decoction,corresponding to 281 targets,among which 240 targets were related to silicosis.Serine/threonine kinase 1(AKT1),tumor protein p53(TP53),tumor necrosis factor(TNF)and interleukin(IL)6 may be the key targets of shengxian and jinshuiliujun decoction in the treatment of silicosis.Through enrichment analysis,30 GO entries and 20 potential signaling pathways were screened according to P-value,including nuclear factor κB(NF-κB),mitogen-activated protein kinase(MAPK)and cancer signaling pathways.Molecular docking showed that the active compounds of shengxian and jinshuiliujun decoction had good binding with the core target proteins,and the strongest binding properties were beta-sitosterol and TNF-α(-10.45 kcal/mol).In animal experiments,the inflammatory infiltration and fibrosis of lung tissue of rats in TCM intervention group were significantly improved.Compared with control group,the levels of TNF-α,IL-1β,IL-6 and NF-κB in lung tissue of model group were significantly increased(P＜0.05).Compared with model group,the lung injury of rats in TCM intervention group was significantly improved,and the expressions of TNF-α,IL-1β,IL-6 and NF-κB were significantly decreased(P＜0.05).Conclusion Shengxian and jinshuiliujun decoction in the treatment of silicosis may play an anti-fibrosis role by inhibiting the NF-κB signal transduction pathway mediated by inflammatory factors such as TNF-α and IL-1β,which provides a reference for further exploring the material basis and mechanism of its action.
维普
万方数据
